About microRNAsTherapeutic OpportunitiesDrugs & Technologies

News & Events

Archived Press Releases

2004  |  2005  |  2007  |  2008  |  2009  |  2010

10.19.04 Alnylam and Isis Receive Exclusive License to Key microRNA Patents for Therapeutic Applications

Media Contacts

Regulus Therapeutics
Zachary Zimmerman, Ph.D.,
858-202-6300

Media
Russo Partners
Heidi Chokeir, Ph.D.,
619-528-2217

Subscribe

Enter your email address to stay up to date with the latest Regulus news.